A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 9,766,728 shares of RXRX stock, worth $72.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,766,728
Previous 9,987,030 2.21%
Holding current value
$72.7 Million
Previous $74.9 Million 14.07%
% of portfolio
0.05%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$5.92 - $8.6 $1.3 Million - $1.89 Million
-220,302 Reduced 2.21%
9,766,728 $64.4 Million
Q2 2024

Jul 19, 2024

SELL
$7.35 - $10.05 $2.76 Million - $3.78 Million
-375,773 Reduced 3.63%
9,987,030 $74.9 Million
Q1 2024

Apr 19, 2024

BUY
$9.13 - $15.52 $10.6 Million - $18 Million
1,159,023 Added 12.59%
10,362,803 $103 Million
Q4 2023

Jan 30, 2024

BUY
$5.09 - $10.79 $28.9 Million - $61.3 Million
5,680,656 Added 161.24%
9,203,780 $90.7 Million
Q3 2023

Oct 30, 2023

BUY
$6.59 - $15.86 $17.7 Million - $42.6 Million
2,685,724 Added 320.72%
3,523,124 $27 Million
Q2 2023

Jul 31, 2023

BUY
$4.56 - $9.94 $1.53 Million - $3.33 Million
335,423 Added 66.82%
837,400 $6.26 Million
Q1 2023

Apr 27, 2023

BUY
$6.42 - $9.64 $304,661 - $457,466
47,455 Added 10.44%
501,977 $3.35 Million
Q4 2022

Jan 30, 2023

SELL
$7.16 - $12.7 $259,320 - $459,968
-36,218 Reduced 7.38%
454,522 $3.5 Million
Q3 2022

Oct 21, 2022

BUY
$7.83 - $13.6 $711,269 - $1.24 Million
90,839 Added 22.72%
490,740 $5.22 Million
Q2 2022

Jul 26, 2022

BUY
$5.04 - $9.26 $2.02 Million - $3.7 Million
399,901 New
399,901 $3.26 Million
Q1 2022

Apr 27, 2022

SELL
$6.16 - $18.03 $2.27 Million - $6.65 Million
-368,994 Closed
0 $0
Q4 2021

Feb 02, 2022

SELL
$16.14 - $21.86 $648,828 - $878,772
-40,200 Reduced 9.82%
368,994 $6.32 Million
Q3 2021

Oct 25, 2021

BUY
$19.03 - $41.33 $3.72 Million - $8.08 Million
195,586 Added 91.56%
409,194 $9.42 Million
Q2 2021

Aug 02, 2021

BUY
$18.0 - $37.42 $3.84 Million - $7.99 Million
213,608 New
213,608 $7.8 Million

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.34B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.